EUVIMEDEUVIMED entdecken
Open Access

Co-Translational Incorporation of ( R )- and ( S )-β 2 -Hydroxyacids In Vivo : Directed Evolution of Efficient Aminoacyl-tRNA Synthetases

Chintan Soni, Meghan Pressimone, Malavika Nair, Kaitlyn Szalay iD, Matthew Hall iD, Noah Hamlish iD, Alexander Carlos Solivan iD, Alanna Schepartz iD, Abhishek Chatterjee iD

Journal of the American Chemical Society · 11.03.2026 · 148 (9) · 9382-9392

DOI: 10.1021/jacs.5c18595 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 27.02.2026. Verfasst von Chintan Soni und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467, United States. Hauptthemen laut MEDLINE: Amino Acyl-tRNA Synthetases, Directed Molecular Evolution, Hydroxy Acids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, Division of Chemistry, National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Expanding the genetic code of living cells with noncanonical monomers (ncMs) relies on engineered aminoacyl-tRNA synthetases (aaRS) and their cognate tRNAs. Conventional aaRS engineering strategies rely on translation-dependent selection systems, limiting their utility for ncMs that are poorly accommodated by the native translational machinery. To address this limitation, we recently developed START, a translation-independent platform that selects Methanomethylophilus alvus pyrrolysyl-synthetase (MaPylRS) mutants based on their ability to acylate cognate tRNAMaPyl. START uses barcoded tRNAs to encode the identity of distinct aaRS mutants in a library. Acylation by active aaRS mutants protects the corresponding tRNAs from periodate oxidation, and their identity is retrieved subsequently through sequencing. START was previously applied to genetically encode noncanonical α-amino acids. Here, we successfully applied START to engineer MaPylRS mutants capable of acylating tRNAMaPyl with diverse non-α-amino acid substrates with good efficiency and fidelity, including (R) and (S) enantiomers of a β2-hydroxy acid, a β2-amino acids, and a malonate. Several mutants exhibit notable polyspecificity across noncanonical backbones while maintaining selectivity against their α-amino acid counterparts. Using these novel enzymes, we demonstrate the ribosomal incorporation of both (R)- and (S)-β2-hydroxy acids into a luciferase reporter protein expressed in Escherichia coli with good efficiency and fidelity. These results imply that highly active engineered aaRS/tRNA pairs can overcome the recently established limitations of EF-Tu with respect to non-α-amino acid substrates. The engineered MaPylRS mutants also enabled the successful incorporation of both (R)- and (S)-β2-hydroxy acids into a protein expressed in mammalian cells, demonstrating for the first time that eukaryotic translation can accommodate non-α-backbones.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amino Acyl-tRNA SynthetasesDirected Molecular EvolutionHydroxy AcidsMethanobacteriaceaeProtein Engineering

Substanzen

Amino Acyl-tRNA SynthetasesHydroxy Acids

Autor:innen und Institutionen

  • Department of Chemistry, Boston College, Chestnut Hill, Massachusetts 02467, United States.
  • Department of Molecular and Cellular Biology, University of California, Berkeley, California 94720, United States.
  • Department of Chemistry, University of California, Berkeley, California 94720, United States.
  • Department of Biology, Boston College, Chestnut Hill, Massachusetts 02467, United States.
  • California Institute for Quantitative Biosciences, University of California, Berkeley, California 94720, United States.
  • Chan Zuckerberg Biohub, San Francisco, California 94158, United States.

ORCID-Profile: Kaitlyn Szalay, Matthew Hall, Noah Hamlish, Alexander Carlos Solivan, Alanna Schepartz, Abhishek Chatterjee

Förderung

  • NIGMS NIH HHS
  • Division of Chemistry
  • National Institute of General Medical Sciences

Zitieren

APA

Soni, C., Pressimone, M., Nair, M., Szalay, K., Hall, M., Hamlish, N., Solivan, A. C., Schepartz, A., & Chatterjee, A. (2026). Co-Translational Incorporation of ( R )- and ( S )-β 2 -Hydroxyacids In Vivo : Directed Evolution of Efficient Aminoacyl-tRNA Synthetases. Journal of the American Chemical Society, 148(9), 9382-9392. https://doi.org/10.1021/jacs.5c18595

Vancouver

Soni C, Pressimone M, Nair M, Szalay K, Hall M, Hamlish N, et al. Co-Translational Incorporation of ( R )- and ( S )-β 2 -Hydroxyacids In Vivo : Directed Evolution of Efficient Aminoacyl-tRNA Synthetases. Journal of the American Chemical Society. 2026;148(9):9382-9392. doi:10.1021/jacs.5c18595

BibTeX
@article{Soni2026,
  author = {Soni, Chintan and Pressimone, Meghan and Nair, Malavika and Szalay, Kaitlyn and Hall, Matthew and Hamlish, Noah and Solivan, Alexander Carlos and Schepartz, Alanna and Chatterjee, Abhishek},
  title = {Co-Translational Incorporation of ( R )- and ( S )-β 2 -Hydroxyacids In Vivo : Directed Evolution of Efficient Aminoacyl-tRNA Synthetases},
  journal = {Journal of the American Chemical Society},
  year = {2026},
  volume = {148},
  number = {9},
  pages = {9382--9392},
  doi = {10.1021/jacs.5c18595}
}
Kostenlos starten →